OCT-based diagnosis of glaucoma and glaucoma stages using explainable machine learning.

Journal: Scientific reports
Published Date:

Abstract

Glaucoma poses a growing health challenge projected to escalate in the coming decades. However, current automated diagnostic approaches on Glaucoma diagnosis solely rely on black-box deep learning models, lacking explainability and trustworthiness. To address the issue, this study uses optical coherence tomography (OCT) images to develop an explainable artificial intelligence (XAI) tool for diagnosing and staging glaucoma, with a focus on its clinical applicability. A total of 334 normal and 268 glaucomatous eyes (86 early, 72 moderate, 110 advanced) were included, signal processing theory was employed, and model interpretability was rigorously evaluated. Leveraging SHapley Additive exPlanations (SHAP)-based global feature ranking and partial dependency analysis (PDA) estimated decision boundary cut-offs on machine learning (ML) models, a novel algorithm was developed to implement an XAI tool. Using the selected features, ML models produce an AUC of 0.96 (95% CI: 0.95-0.98), 0.98 (95% CI: 0.96-1.00) and 1.00 (95% CI: 1.00-1.00) respectively on differentiating early, moderate and advanced glaucoma patients. Overall, machine outperformed clinicians in the early stage and overall glaucoma diagnosis with 10.4 -11.2% higher accuracy. The developed user-friendly XAI software tool shows potential as a valuable tool for eye care practitioners, offering transparent and interpretable insights to improve decision-making.

Authors

  • Md Mahmudul Hasan
    Queensland University of Technology (QUT), Centre for Accident Research and Road Safety Queensland (CARRS-Q), Australia; Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI), Australia. Electronic address: mahmudul.hasan.eee.kuet@gmail.com.
  • Jack Phu
    Centre for Eye Health, School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.
  • Henrietta Wang
    School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, Australia.
  • Arcot Sowmya
    School of Computer Science and Engineering, UNSW Sydney, Sydney, Australia.
  • Michael Kalloniatis
    Centre for Eye Health, and School of Optometry and Vision Science, The University of New South Wales, Kensington, Australia.
  • Erik Meijering
    Biomedical Imaging Group Rotterdam, Departments of Medical Informatics and Radiology, Erasmus University Medical Center, Rotterdam, the Netherlands.